These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 11726217

  • 1. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
    Yuen MF, Norris S.
    Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
    [Abstract] [Full Text] [Related]

  • 2. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I.
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 4. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
    Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, Shi M, Zhang H, Yang Y, Wu H, Tien P, Wang FS.
    Clin Immunol; 2008 Dec 01; 129(3):428-37. PubMed ID: 18824414
    [Abstract] [Full Text] [Related]

  • 5. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A, Tsiatas ML, Kafantari E, Liakou C, Rodolakis A, Voulgaris Z, Vlahos G, Papageorgiou T, Tsitsilonis O, Bamia C, Papatheodoridis G, Politi E, Archimandritis A, Antsaklis A, Dimopoulos MA.
    Gynecol Oncol; 2007 Jul 01; 106(1):75-81. PubMed ID: 17433425
    [Abstract] [Full Text] [Related]

  • 6. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX, Wang XY, Liu JB, Zhang SQ, Chen YR.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):973-6. PubMed ID: 18756970
    [Abstract] [Full Text] [Related]

  • 7. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr 08; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 8. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL.
    Clin Cancer Res; 1996 Jan 08; 2(1):161-73. PubMed ID: 9816103
    [Abstract] [Full Text] [Related]

  • 9. Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures.
    Ntrivalas EI, Bowser CR, Kwak-Kim J, Beaman KD, Gilman-Sachs A.
    Am J Reprod Immunol; 2005 May 08; 53(5):215-21. PubMed ID: 15833099
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response.
    Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, Cerioni S, Fagnoni F, Soliani P, Ferrari C, Missale G.
    Gastroenterology; 2010 May 08; 138(5):1931-42. PubMed ID: 20060829
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.
    Chen CH, Lee HS, Huang GT, Yang PM, Yu WY, Cheng KC, Lee PH, Jeng YM, Chen DS, Sheu JC.
    Hepatogastroenterology; 2007 May 08; 54(77):1529-33. PubMed ID: 17708291
    [Abstract] [Full Text] [Related]

  • 12. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
    Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, Liu JC, Fan ZP, Li HW, Mu JS, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2049-53. PubMed ID: 14703414
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
    Eidukaite A, Siaurys A, Tamosiunas V.
    Fertil Steril; 2004 Mar 10; 81 Suppl 1():863-8. PubMed ID: 15019821
    [Abstract] [Full Text] [Related]

  • 14. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G.
    Cancer; 2008 Feb 15; 112(4):863-75. PubMed ID: 18203207
    [Abstract] [Full Text] [Related]

  • 15. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH.
    Hepatogastroenterology; 2008 Feb 15; 55(82-83):345-50. PubMed ID: 18613363
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF.
    Br J Dermatol; 2006 Aug 15; 155(2):318-24. PubMed ID: 16882169
    [Abstract] [Full Text] [Related]

  • 17. Induction by OK-432 of lymphokine activated killer precursor cells in hepatocellular carcinoma.
    Aramaki M, Kim YI, Shimoda K, Nakashima K, Okada K, Kobayashi M.
    Hepatogastroenterology; 1994 Aug 15; 41(4):363-6. PubMed ID: 7959572
    [Abstract] [Full Text] [Related]

  • 18. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM, Wu PH, Zhao M, Wang QJ, Huang LX, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 Nov 15; 25(11):1414-8. PubMed ID: 17094912
    [Abstract] [Full Text] [Related]

  • 19. Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.
    Doskali M, Tanaka Y, Ohira M, Ishiyama K, Tashiro H, Chayama K, Ohdan H.
    J Immunother; 2011 Mar 15; 34(2):129-38. PubMed ID: 21304407
    [Abstract] [Full Text] [Related]

  • 20. [Induction of anti-cancer cells and systemic immune response in hepatocellular carcinoma by OK-432].
    Aramaki M, Nakashima K, Sasaki A, Shimoda K, Yoshida T, Kim YI, Kitano S, Kobayashi M.
    Gan To Kagaku Ryoho; 1994 Sep 15; 21(13):2115-7. PubMed ID: 7944416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.